Vontobel Holding Ltd. Sells 35,737 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Vontobel Holding Ltd. cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 46.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 42,013 shares of the pharmacy operator’s stock after selling 35,737 shares during the period. Vontobel Holding Ltd.’s holdings in Walgreens Boots Alliance were worth $1,097,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of WBA. EverSource Wealth Advisors LLC increased its position in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 845 shares during the last quarter. Highlander Capital Management LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Venturi Wealth Management LLC grew its position in Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. FinTrust Capital Advisors LLC grew its position in Walgreens Boots Alliance by 2,314.5% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC bought a new position in Walgreens Boots Alliance during the 4th quarter worth approximately $30,000. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on WBA shares. Bank of America reduced their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Truist Financial restated a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Morgan Stanley reduced their price target on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research report on Monday, April 1st. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, SVB Leerink dropped their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a report on Monday, March 18th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $24.36.

Insider Activity

In other news, Director Valerie B. Jarrett bought 4,456 shares of the stock in a transaction dated Monday, January 29th. The stock was bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the purchase, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the stock in a transaction on Thursday, April 11th. The stock was acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Valerie B. Jarrett acquired 4,456 shares of the stock in a transaction on Monday, January 29th. The shares were bought at an average price of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now directly owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Insiders bought a total of 13,456 shares of company stock worth $270,423 in the last quarter. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Trading Up 3.7 %

WBA opened at $18.24 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The business has a 50 day moving average of $20.42 and a 200-day moving average of $21.92. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $36.14.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.16 EPS. As a group, research analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.